We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Moderna has signed a new agreement with Lonza to create a new production line at the latter’s Geleen facility in the Netherlands, which will support drug substance production for its international supply chain.